COVID-19

Researchers continued to investigate how to help allergy and asthma patients breathe easier, eat better, and live safer and more satisfying lives in 2022. Here are our top 10 stories about these developments this year.

The COVID-19 pandemic may have had an effect on treatment approaches for patients with multiple myeloma, according to study results presented at ASH Annual Meeting and Exposition.

Resilience and organizational support protected against burnout, while social support and resilience led to better mental health outcomes among health care workers a year after the COVID-19 pandemic.

People with MS who are being treated with rituximab are strongly encouraged to receive mRNA SARS-CoV-2 vaccines and booster doses more than 6 months after their last rituximab infusion, researchers reported in JAMA Network Open.

Nearly 3 years into the pandemic, COVID-19 continues to dominate headlines and research labs as scientists explore therapies that mitigate the impact of the virus, particularly among patients with asthma and allergy.

An asymptomatic SARS-CoV-2 patient admission testing program can provide clinically relevant data, even during periods of lower transmission in which testing can be limited to patients who are not fully vaccinated, a recent study showed.

During motorcycle rallies, researchers noticed a 21% increase in organs donated per day and a 26% increase in daily transplant recipients compared with the days before and after these events.

As asthma affects significant proportions of the population, research strove to improve the lives of these patients in 2022. Here are Healio’s 10 most popular stories about these developments.

The most-read cover story published by Healio Rheumatology in 2022 delved into the issue of paid family leave, examining the stigma and systematic barriers that prevent physicians from taking time away from work.

Even in the COVID-19 era, atherosclerotic CVD remains the leading cause of death worldwide.